norUDCA in experimental alcoholic liver disease
收藏NIAID Data Ecosystem2026-03-14 收录
官方服务：
资源简介：
Alcoholic liver disease is a global health care concern with limited treatment options. NorUDCA is a modified bile acid, which was proven to be effective in human cholestatic liver diseases. In the present study we found a protective effect of norUDCA in experimental alcoholic liver disease. Sequencing was performed at the Joint Microbiome Facility of the Medical University of Vienna and the University of Vienna under the project ID JMF-2108-05.
创建时间：
2022-12-01
